Cardiac function and incidence of unexplained myocardial scarring in patients with primary carnitine deficiency - a cardiac magnetic resonance study
Open Access
- 26 September 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-7
Abstract
Primary carnitine deficiency (PCD) not treated with L-Carnitine can lead to sudden cardiac death. To our knowledge, it is unknown if asymptomatic patients treated with L-Carnitine suffer from myocardial scarring and thus be at greater risk of potentially serious arrhythmia. Cardiac evaluation of function and myocardial scarring is non-invasively best supported by cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE). The study included 36 PCD patients, 17 carriers and 17 healthy subjects. A CMR cine stack in the short-axis plane were acquired to evaluate left ventricle (LV) systolic and diastolic function and a similar LGE stack to evaluate myocardial scarring and replacement fibrosis. LV volumes and ejection fraction were not different between PCD patients, carriers and healthy subjects. However, LV mass was higher in PCD patients with the severe homozygous mutation, c.95 A > G (p = 0.037; n = 17). Among homozygous PCD patients there were two cases of unexplained myocardial scarring and this is in contrast to no myocardial scarring in any of the other study participants (p = 0.10). LV mass was increased in PCD patients. L-carnitine supplementation is essential in order to prevent potentially lethal cardiac arrhythmia and serious adverse cardiac remodeling.Keywords
Funding Information
- The Faroese Research Council
This publication has 31 references indexed in Scilit:
- Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screeningJournal of Inherited Metabolic Disease, 2013
- Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe IslandsJournal of Inherited Metabolic Disease, 2013
- Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-upInternational Journal of Cardiology, 2013
- Prognostic Significance of Myocardial Fibrosis in Hypertrophic CardiomyopathyJACC, 2010
- Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stressAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Myofibroblasts Induce Ectopic Activity in Cardiac TissueCirculation Research, 2007
- The Expanding Prognostic Role of Late Gadolinium Enhanced Cardiac Magnetic Resonance⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.JACC, 2006
- Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation/carnitine transporter OCTN2Journal of Inherited Metabolic Disease, 2003
- Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiencyMolecular Genetics and Metabolism, 2002
- Dilated cardiomyopathy caused by plasma membrane carnitine transport defectJournal of Inherited Metabolic Disease, 1998